ALiA BioTech is a biotechnology and healthcare company founded in December 2012 with a compelling vision - "Accurate Assay Anywhere". The company's core team comprises founders with diverse backgrounds in business, biotechnology, advanced micromachining, and microfluidic Lab On Chip (LOC) platform. This multidisciplinary expertise has been instrumental in the development of a rapid diagnostic, mobile platform for faster and more accurate diagnosis of time-critical and life-threatening diseases.
ALiA BioTech sees impending changes in the conventional clinical diagnostic and academic R&D for bio-discoveries, and aims to be a driving force in revolutionizing healthcare solutions for the future. Their innovative approach is manifested through the delivery of accurate and actionable information via disposable Lab-On-Chip (LOC) rapid diagnostic platforms, leading to transformative diagnostic tests for faster clinical decisions and improved economic outcomes.
Headquartered in Hong Kong S.a.r., ALiA BioTech is at the forefront of leveraging technology and biotechnology to address critical gaps in healthcare. With an unwavering commitment to advancing diagnostic solutions, the company holds significant promise for future investments and has the potential to attract visionary investors who recognize the pivotal role of rapid and accurate diagnostics in shaping the future of healthcare.
There is no investment information
No recent news or press coverage available for ALiA BioTech .